Global Genetic Testing Market Outlook 2026–2030: Precision Medicine, Technology Advances and Expanding Applications Unlock New Growth Opportunities
Dublin, Sept. 24, 2026 (GLOBE NEWSWIRE) -- "Genetic Testing Markets 12th Edition. Global Market Analysis with Forecasts by Applications, Technologies, Products and Users with Executive and Consultant Guides 2026 to 2030" has been added to ResearchAndMarkets.com's offering.
Genetic Testing Market Report Examines Global Growth Opportunities, Emerging Applications and Five-Year Forecasts
The genetic testing market has entered a period of significant expansion as scientific advances, broader clinical adoption and declining testing costs accelerate demand worldwide. A new market research report evaluates this rapidly evolving industry, highlighting key opportunities, competitive challenges and potential risks for organizations seeking to participate in its continued growth.
Genetics is playing an increasingly important role in understanding health, disease risk, treatment response and clinical decision-making. As knowledge advances, genetic testing is expanding beyond traditional applications and creating opportunities across predictive diagnostics, pharmacogenomic testing, direct-to-consumer genetic testing and other emerging areas. At the same time, the growing volume and diversity of available tests are introducing new operational, commercial and industry-wide considerations.
The report provides a comprehensive assessment of the global genetic testing market, including detailed analysis for 14 countries and five major regions. This geographic coverage enables companies, investors and other industry participants to compare market conditions, identify areas of potential growth and evaluate how adoption may develop across established and emerging markets.
In addition to examining current market dynamics, the research analyzes the technologies and applications influencing genetic testing industry growth. It considers the expanding breadth of testing services, changing market demand and the factors that may affect commercialization. Coverage of predictive diagnostics, pharmacogenomics and direct-to-consumer testing offers insight into several of the market's most closely watched segments.
The genetic testing industry presents substantial commercial potential, but continued expansion also creates challenges. Organizations must assess evolving testing models, pricing pressures, market access, adoption patterns and the implications of a growing number of available tests. The report evaluates both opportunities and pitfalls, helping decision-makers develop strategies grounded in current data and realistic market expectations.
Five-year genetic testing market forecasts provide a forward-looking view of expected industry performance. These projections are designed to help readers understand potential growth trajectories, assess long-term demand and evaluate the market outlook across technologies, applications and geographic areas.
Key areas addressed in the report include:
As genetic testing becomes more widely integrated into healthcare and consumer markets, reliable intelligence is essential for navigating a complex competitive environment. The report brings together current market data, regional analysis and forward-looking projections to support informed business planning.
Companies can use the findings to evaluate market entry, prioritize investment opportunities, compare regional potential and strengthen strategic decision-making. Investors and financial professionals can also apply the report's data and forecasts when assessing valuations, growth expectations and the long-term commercial potential of genetic testing businesses.
With the genetic testing market continuing to grow in both volume and scope, this research offers a timely resource for stakeholders seeking to understand where the industry is heading. Its combination of country-level insights, regional analysis, technology coverage and five-year market forecasts provides a clear foundation for identifying opportunities while recognizing the risks that may shape future growth.
Key Attributes:
Key Topics Covered:
1 Market Guides
1.1 Genetic Testing - Strategic Situation Analysis
1.2 Guide for Executives, Marketing, Sales and Business Development Staff
1.3 Guide for Management Consultants and Investment Advisors
1.4 Impact of Artificial Intelligence
2 Introduction and Market Definition
2.1 Genetic Testing Definition in This Report
2.2 The Genomics Revolution
2.3 Market Definition
2.3.1 Revenue Market Size.
2.3.2 Newborn Screening
2.3.3 Non Invasise Pregnancy Testing
2.3.4 Predictive
2.3.5 Oncology
2.3.6 Direct to Consumer
2.3.7 Other Application
2.3.8 PCR
2.3.9 NGS
2.3.10 Cytogenetic
2.3.11 Other Technology
2.4 Methodology
2.4.1 Methodology
2.4.2 Sources
2.4.3 Authors
2.5 Perspective: Healthcare Spending
2.5.1 Global Healthcare Spending
2.5.2 Spending on Healthcare and Pharmaceuticals
2.5.3 Spending on Diagnostics
2.5.4 Important Role of Insurance for Medical Services
2.6 Chromosomes, Genes and Epigenetics
2.6.1 Chromosomes
2.6.2 Genes
2.6.3 Epigenetics
3 Market Overview
3.1 Players in a Dynamic Market
3.1.1 Academic Research Lab
3.1.2 Diagnostic Test Developer
3.1.3 Instrumentation Supplier
3.1.4 Chemical/Reagent Supplier
3.1.5 Pathology Supplier
3.1.6 Independent Clinical Laboratory
3.1.7 Public National/regional Laboratory
3.1.8 Hospital Laboratory
3.1.9 Physicians Office Lab (POLS)
3.1.10 Audit Body
3.1.11 Certification Body
3.2 Genetic Tests -Types, Examples and Discussion
3.2.1 Preimplantation Genetic Diagnosis- An Emerging Market
3.2.2 Prenatal Diagnosis - New Technologies Create Opportunity
3.2.3 Newborn Screening
3.2.4 Diagnostic Testing
3.2.5 Carrier Testing
3.2.6 Predictive and Presymptomatic Testing
3.2.7 Pharmacogenomics
3.2.8 Forensic Testing
3.2.9 Parental Testing
3.2.10 Ancestral Testing
3.3 Industry Structure
3.3.1 Hospital's Testing Share
3.3.2 Economies of Scale
3.3.3 Hospital vs. Central Lab
3.3.4 Physician Office Lab's
3.3.5 Physician's and POCT
4 Market Trends
4.1 Factors Driving Growth
4.1.1 Genetic Discoveries Impact.
4.1.2 The Aging Effect
4.1.3 Pharmacogenomics
4.1.4 Oncology and Liquid Biopsy Factors
4.1.5 Fertility Practice
4.1.6 Direct to Consumer
4.2 Factors Limiting Growth
4.2.1 The Competition Effect
4.2.2 The Cost Situation
4.2.3 Testing usage analysis
4.2.4 Wellness Effects
4.3 Instrumentation, Automation and Diagnostic Trends
4.3.1 Traditional Automation and Centralization
4.3.2 The New Automation, Decentralization and Point of Care
4.3.3 Instruments Key to Market Share
4.3.4 Bioinformatics Plays a Role
4.3.5 PCR Takes Command
4.3.6 Next Generation Sequencing Fuels a Revolution
4.3.7 NGS Impact on Pricing
4.3.8 Whole Genome Sequencing, A Brave New World
4.3.9 Companion Diagnostics Blurs Diagnosis and Treatment
4.3.10 Shifting Role of Diagnostics
5 Genetic Testing Recent Developments
5.1 Recent Developments
5.1.1 Importance of This Section
5.1.2 How to Use This Section
5.2 Johns Hopkins Creates New Urine-based Cancer Test
5.3 23andMe's founder Anne Wojcicki wins bid for bankrupt DNA testing firm
5.4 GeneDx Announces Completion of Fabric Genomics Acquisition
5.5 QIAGEN acquires Genoox AI-powered software
5.6 23andMe Launches New Genetic Report
5.7 Natera Revenues Soar on Product Gains
5.7.1 Tempus Completes Acquisition of Ambry Genetics
5.8 GeneDx Launches Exome Testing for Epilepsy
5.9 Owkin, AstraZeneca Partner to Develop AI Breast Cancer Prescreening Tool
5.10 Myriad Genetics Reports Revenue Spike
5.11 GeneDx Revenues Grow 45 Percent
5.12 Revvity Launches NGS Panel for Newborn Screening
5.13 LetsGetChecked: MyGeneticScreen
5.14 Sysmex, Hitachi to Develop Low-Cost Sequencers
5.15 Fore Genomics Offering WGS Newborn Screening to Parents
5.16 Clinical Validation of Long-Read WGS Assay
5.17 Resolution Bio Acquisition - Exact Sciences Aims at Liquid Biopsy Market
5.18 Novitas Rescinds Coverage for Multiple Genetic Tests
5.19 PerkinElmer (now Revvity) Becomes Dx Life Science Firm
5.20 New POC Genotyping Tests Based on Electromagnetic Detection
5.21 GenoMe Dx Launching dPCR Cancer Test
5.22 mDetect To Trial Breast Cancer Liquid Biopsy
5.23 Genomics England, Aims to Sequence 100K Newborns
5.24 Juno Diagnostics NIPT With At-Home Sample Collection
5.25 Cardio Diagnostics Launches Genetic Cario Risk Test
5.26 Universal Genetic Testing in Breast Cancer Further Supported
5.27 Aniling Gets CE-IVD Marks for Cancer Sequencing Tests
5.28 MyOme Lands Investment for WGS
5.29 Type 2 Diabetes GWAS Enables Risk Prediction
5.30 LetsGetChecked to Acquire Veritas Genetics
5.31 Guardant Health Plans New Comprehensive Assay
5.32 Tesis Labs Raises $20M
5.33 Sema4: Sema4 Elements
5.34 Clarified Precision Medicine Acquires Interpares Biomedicine
5.35 Genetic Technologies to Acquire DTC Genetic Test Provider EasyDNA
5.36 Illumina, Belgium Genetic Centers Partner on WGS-Based Dx
5.37 NIH, Genomics England Launch Sequencing Studies Using Nanopore Technology
5.38 Progenity Revenues Fall on COVID-19 Effect
5.39 Natera Launches Tumor Genomic Profiling Assay
5.40 23andMe To Go Public
5.41 Guardant Health to Offer Tumor Tissue Sequencing
5.42 Ancestry Quits Health Offering
5.43 DTC Firm MyDNA Merges With Gene by Gene
6 Profiles of Key Companies
6.1 10x Genomics, Inc.
6.2 23andME Inc.
6.3 Abbott Laboratories
6.4 Adaptive Biotechnologies
6.5 Admera Health, LLC
6.6 Agilent
6.7 Akonni Biosystems
6.8 Amoy Diagnostics Co., Ltd.
6.9 Ancestry.com LLC
6.10 Anchor Dx
6.11 Arrayit Corporation
6.12 ARUP Laboratories
6.13 Aus Diagnostics
6.14 BaseClear
6.15 Baylor Miraca Genetics Laboratories
6.16 Beckman Coulter Diagnostics (Danaher)
6.17 Becton, Dickinson and Company
6.18 BGI Genomics Co. Ltd
6.19 Bioarray Genetics
6.20 BioBam
6.21 Biocept, Inc.
6.22 Biodesix Inc.
6.23 BioFluidica
6.24 BioGenex
6.25 BioGX
6.26 Biolidics Ltd
6.27 bioMerieux Diagnostics
6.28 Bioneer Corporation
6.29 Bio-Rad Laboratories, Inc.
6.30 Bio-Techne
6.31 Burning Rock
6.32 C2i Genomics
6.33 Cantata Bio
6.34 CareDx
6.35 Caris Molecular Diagnostics
6.36 Celemics
6.37 CellMax Life
6.38 Centogene
6.39 Cepheid (Danaher)
6.40 Circulogene
6.41 Clearbridge Biomedics
6.42 Clinical Genomics
6.43 Color Genomics
6.44 Complete Genomics (MGI Tech)
6.45 CosmosID
6.46 Dante Labs
6.47 Datar Cancer Genetics Limited
6.48 Diasorin S.p.A.
6.49 DNAe
6.50 Easy DNA
6.51 Element Biosciences
6.52 Epic Sciences
6.53 Epigenomics AG
6.54 Eurofins Scientific
6.55 Excellerate Bioscience
6.56 Fabric Genomics
6.57 Freenome
6.58 FUJIFILM Wako Diagnostics
6.59 Fujirebio
6.60 Fulgent Genetics
6.61 Gene by Gene, Ltd.
6.62 Genedrive
6.63 GeneDx Holdings
6.64 GeneFirst Ltd.
6.65 Genetic Technologies Ltd.
6.66 Genetron Holdings
6.67 Genolution
6.68 Genomics England
6.69 Genomics Personalized Health (GPH)
6.70 GenomOncology
6.71 Genzyme Corporation
6.72 Grifols
6.73 Guardant Health
6.74 Guardiome
6.75 Helix
6.76 Hologic
6.77 HTG Molecular Diagnostics
6.78 Human Longevity, Inc.
6.79 iCellate
6.80 Illumina
6.81 Incell Dx
6.82 Inivata
6.83 Invitae Corporation
6.84 Invivoscribe
6.85 Karius
6.86 Letsgetchecked
6.87 Lunglife AI Inc
6.88 Macrogen
6.89 MDNA Life SCIENCES, Inc.
6.90 MDx Health
6.91 Medgenome
6.92 Menarini Silicon Biosystems
6.93 Meridian Bioscience
6.94 Mesa Laboratories, Inc.
6.95 Metabiomics Corp
6.96 miR Scientific
6.97 NantHealth, Inc.
6.98 Natera
6.99 Nebula Genomics
6.100 NeoGenomics
6.101 New England Biolabs, Inc.
6.102 NGeneBio
6.103 Norgen Biotek Corp.
6.104 Novogene
6.105 Omega Bioservices
6.106 Oncocyte
6.107 OncoDNA
6.108 OpGen
6.109 Origene Technologies
6.110 Oxford Nanopore Technologies
6.111 Pacific Biosciences
6.112 Panagene
6.113 PathoQuest S.A.
6.114 Personalis
6.115 PGDx (Labcorp)
6.116 Precipio
6.117 PrecisionMed
6.118 Predictive Oncology
6.119 Promega
6.120 Qiagen
6.121 QuantuMDx
6.122 Revvity
6.123 Roche Diagnostics
6.124 Roswell Biotechnologies
6.125 Seegene
6.126 Sequencing.com
6.127 Siemens Healthineers
6.128 simfo GmbH
6.129 Singlera Genomics Inc.
6.130 Singular Genomics
6.131 SkylineDx
6.132 Standard BioTools
6.133 Sysmex
6.134 Sysmex Inostics
6.135 Tempus Labs, Inc.
6.136 Thermo Fisher Scientific
6.137 Ultima Genomics
6.138 Variantyx
6.139 Vela Diagnostics
6.140 VolitionRX
6.141 Zymo Research Corp
7 Global Market Size
7.1 Global Market by Country
7.1.1 Table - Global Market by Country
7.1.2 Chart - Country Market Shares
7.2 Global Market by Application
7.2.1 Table - Global Market by Application
7.2.2 Chart - Application Share by Year
7.2.3 Chart - Application Segment Growth Rates
7.2.4 Chart - Application Segment Share Shifts
7.2.5 Chart - Application Segment Share Base Year
7.2.6 Chart - Application Segment Share Final Year
7.3 Global Market by Technology
7.3.1 Table - Global Market by Technology
7.3.2 Chart - Technology Share by Year
7.3.3 Chart - Technology Segment Growth Rates
7.3.4 Chart - Technology Segment Share Shifts
7.3.5 Chart - Technology Segment Share Base Year
7.3.6 Chart - Technology Segment Share Final Year
7.4 Global Market by Product
7.4.1 Table - Global Market by Product
7.4.2 Chart - Product Share by Year
7.4.3 Chart - Product Segment Growth Rates
7.4.4 Chart - Product Segment Share Shifts
7.4.5 Chart - Product Segment Share Base Year
7.4.6 Chart - Product Segment Share Final Year
7.5 Global Market by User
7.5.1 Table - Global Market by User
7.5.2 Chart - User Share by Year
7.5.3 Chart - User Segment Growth Rates
7.5.4 Chart - User Segment Share Shifts
7.5.5 Chart - User Segment Share Base Year
7.5.6 Chart - User Segment Share Final Year
8 Market Sizes by Application
8.1 Newborn Testing Market
8.1.1 Table Newborn - by Country
8.1.2 Chart - Newborn Growth
8.2 NIPT Market
8.2.1 Table NIPT - by Country
8.2.2 Chart - NIPT Growth
8.3 Predictive Testing Market
8.3.1 Table Predictive - by Country
8.3.2 Chart - Predictive Growth
8.4 Oncology Testing Market
8.4.1 Table Oncology - by Country
8.4.2 Chart - Oncology Growth
8.5 DTC Testing Market
8.5.1 Table DTC - by Country
8.5.2 Chart - DTC Growth
8.6 Other Testing Market
8.6.1 Table Other - by Country
8.6.2 Chart - Other Growth
9 Global Genetic Testing Market by Technology
9.1 PCR Testing Market
9.1.1 Table PCR - by Country
9.1.2 Chart - PCR Growth
9.2 NGS Market
9.2.1 Table NGS - by Country
9.2.2 Chart - NGS Growth
9.3 Cytogenetic Testing Market
9.3.1 Table Cytogenetic - by Country
9.3.2 Cytogenetic - Predictive Growth
9.4 Other Testing Market
9.4.1 Table Other - by Country
9.4.2 Chart - Other Growth
10 Global Genetic Testing Market by Product
10.1 Instruments Market
10.1.1 Table Instruments - by Country
10.1.2 Chart - Instrument Growth
10.2 Reagents and Kits Market
10.2.1 Table Reagents and Kits - by Country
10.2.2 Chart - Reagents and Kits Growth
10.3 Software Market
10.3.1 Table Software - by Country
10.3.2 Software Growth
10.4 Services Market
10.4.1 Table Services - by Country
10.4.2 Chart - Services Growth
11 Global Genetic Testing Market by User
11.1 Academic Market
11.1.1 Table Academic - by Country
11.1.2 Chart - Academic Growth
11.2 Clinical Market
11.2.1 Table Clinical - by Country
11.2.2 Chart - Clinical Growth
11.3 Pharmaceutical Market
11.3.1 Table Pharmaceutical - by Country
11.3.2 Pharmaceutical - Predictive Growth
11.4 Industrial and Other Market
11.4.1 Table Industrial and Other - by Country
11.4.2 Chart - Industrial and Other Growth
12 The Future of Genetic Testing
13 Appendices
13.1 Growth of Approved IVD Test Menu
13.2 Growth of Approved Average IVD Test Fee
13.3 The Most Used IVD Assays
13.4 The Highest Grossing Assays
13.5 Laboratory Fees Schedule
Table of Tables
Table 1 Most Common Traditional Genetic Disorders
Table 2 The Base Pairs
Table 3 Market Players by Type
Table 4 The Different Types of Genetic Tests
Table 5 Five Factors Driving Growth
Table 6 Four Factors Limiting Growth
Table 7 Seven Key Diagnostic Laboratory Technology Trends
Table 8 Global Market by Country
Table 9 Global Market by Application
Table 10 Global Market by Technology
Table 11 Global Market by Product
Table 12 Global Market by User
Table 13 Newborn Segment by Country
Table 14 NIPT Segment by Country
Table 15 Predictive Segment by Country
Table 16 Oncology Segment by Country
Table 17 DTC Segment by Country
Table 18 Other Segment by Country
Table 19 PCR Segment by Country
Table 20 NGS Segment by Country
Table 21 Cytogenetic Segment by Country
Table 22 Other Segment by Country
Table 23 Instruments Segment by Country
Table 24 Reagents and Kits Segment by Country
Table 25 Software Segment by Country
Table 26 Services Segment by Country
Table 27 Academic Segment by Country
Table 28 Clinical Segment by Country
Table 29 Pharmaceutical Segment by Country
Table 30 Industrial and Other Segment by Country
Table 31 The Most Common Assays
Table 32 Largest Revenue Assays
Table 33 Clinical Lab Fee Schedule
Table of Figures
Figure 1 Global Healthcare Spending
Figure 2 DNA Strands and Chromosomes
Figure 3 Karyogram of Human Chromosomes
Figure 4 Size of Various Genomes
Figure 5 The Road to Diagnostics
Figure 6 The Changing Age of the World Population
Figure 7 Health Care Consumption by Age
Figure 8 Cancer Incidence - Age at Diagnosis
Figure 9 Centralized vs. Decentralized Laboratory Service
Figure 10 A Highly Multiplexed Syndromic Testing Unit
Figure 11 The Real Cost to Sequence the Human Genome
Figure 12 The Codevelopment Process
Figure 13 Comparing MDx Diagnostic and Traditional Testing
Figure 14 Country Market Shares
Figure 15 Application Share by Year
Figure 16 Application Segment Growth Rates
Figure 17 Segment Share Shifts
Figure 18 Application Segment Share Base Year
Figure 19 Application Segment Share Final Year
Figure 20 Technology Share by Year
Figure 21 Technology Segment Growth Rates
Figure 22 Technology Segment Share Shifts
Figure 23 Technology Segment Share Base Year
Figure 24 Technology Segment Share Final Year
Figure 25 Product Share by Year
Figure 26 Product Segment Growth Rates
Figure 27 Product Segment Share Shifts
Figure 28 Product Segment Share Base Year
Figure 29 Product Segment Share Final Year
Figure 30 User Share by Year
Figure 31 User Segment Growth Rates
Figure 32 User Segment Share Shifts
Figure 33 User Segment Share Base Year
Figure 34 User Segment Share Final Year
Figure 35 Newborn vs. Total Market Growth
Figure 36 NIPT vs. Total Market Growth
Figure 37 Predictive vs. Total Market Growth
Figure 38 Oncology vs. Total Market Growth
Figure 39 DTC vs. Total Market Growth
Figure 40 Other vs. Total Market Growth
Figure 41 PCR vs. Total Market Growth
Figure 42 NGS vs. Total Market Growth
Figure 43 Cytogenetic vs. Total Market Growth
Figure 44 Other vs. Total Market Growth
Figure 45 Instrument vs. Total Market Growth
Figure 46 Reagents and Kits vs. Total Market Growth
Figure 47 Software vs. Total Market Growth
Figure 48 Services vs. Total Market Growth
Figure 49 Academic vs. Total Market Growth
Figure 50 Clinical vs. Total Market Growth
Figure 51 Pharmaceutical vs. Total Market Growth
Figure 52 Industrial and Other vs. Total Market Growth
Figure 53 IVD Test Menu Growth
Figure 54 IVD Test Average Fees - A Ten Year View
Companies Featured
For more information about this report visit https://www.researchandmarkets.com/r/623fjy
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.